Professor and Medical Oncologist Silke Gillessen and Professor Nick James of the Institute of Cancer and Genomic Sciences at the University of Birmingham discuss the results of the randomized RADICALS trial that explores the duration of adjuvant/salvage androgen ablation with XRT in prostate cancer.